EMPIRE BIO A/S: Financial statements 2013
CVR: 12627343
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
EMPIRE BIO A/S (CVR 12627343) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 7,652,076 and a net result of DKK 1,353,083 compared with DKK 1,480,608 the year before. That is a decrease of 1% compared with the year before. Equity in the 2013 report amounted to DKK 3,655,476. The solvency ratio was 44.1%.
- Gross Profit
- DKK 7,652,076
- Profit/Loss
- DKK 1,353,083
- Equity
- DKK 3,655,476
- Total Assets
- DKK 8,281,560
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
As of November 20, 2013, Erik Pontus Weman has joined the board of directors of EMPIRE BIO A/S.
As of November 20, 2013, Christer Öberg has left the board of directors of EMPIRE BIO A/S.
EMPIRE BIO A/S has published its annual report for 2012. Gross profit came to DKK 7,728,370, and the net result was DKK 1,480,608.
About EMPIRE BIO A/S
EMPIRE BIO A/S is a Danish company of the type Aktieselskab based in København N, founded in 1988. The company is registered under the industry Fremvisning af film og andre billedmedier. The company was previously named EMPIRE STAGE BUILDING ApS and ApS KBUS 8 NR. 3654. The management consists of Mette Schramm. The board consists of Karl Peter Fornstam (chair), Claus Norreen, Karl Mikael Håland and Mette Schramm. The company's owners include DANNY RED HOLDING ApS, REEL PICTURES ApS and SR Holding af 2019 ApS. The company has 43 employees (2026). In 2025, the company reported a gross profit of DKK 6,676,804 and a net result of DKK -54,528 compared with DKK -326,674 the year before. Equity in the 2025 report amounted to DKK 4,178,551.